Sarepta Therapeutics’ Pullback After Current FDA Approval A Shopping for Alternative (SRPT)
JOSE LUIS CALVO MARTIN & JOSE ENRIQUE GARCIA-MAURIÑO MUZQUIZ Sarepta Therapeutics, Inc. (NASDAQ:SRPT) is synonymous with Duchenne Muscular Dystrophy ("DMD"). ...
